X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2024-67267.pdf
https://www.contractpharma.com/contents/view_breaking-news/2022-10-11/chargepoint-and-steris-partner-to-provide-a-sterile-solution-to-evonik/
https://www.globenewswire.com/news-release/2022/10/10/2531009/34752/en/TOMI-to-Install-Custom-Engineered-Integrated-iHP-System-in-Avid-Bioservices-Inc-Viral-Vector-Manufacturing-Facility-in-California.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-27-2022-1659339221.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-20-2022-1658293362.pdf
https://www.prnewswire.com/news-releases/new-research-demonstrates-synexis-dhp-technology-eliminates-99-99-sars-cov-2-delta-variant-in-air-301440826.html
https://www.biospace.com/article/releases/galera-therapeutics-announces-dosing-of-first-patient-in-a-randomized-double-blind-pilot-phase-2-clinical-trial-of-gc4419-for-covid-19/
https://www.fiercepharma.com/marketing/fda-promo-police-reprimand-aclaris-for-eskata-misleading-risks-and-efficacy-video-aired?utm_source=internal&utm_medium=rss
https://www.prnewswire.com/news-releases/american-journal-of-infection-control-publishes-tso3-study-on-terminal-sterilization-of-duodenoscopes-300751653.html
https://globenewswire.com/news-release/2017/12/15/1262708/0/en/Aclaris-Therapeutics-Receives-FDA-Approval-for-ESKATA-Hydrogen-Peroxide-Topical-Solution-40-w-w-for-the-Treatment-of-Raised-Seborrheic-Keratoses-SKs.html
https://www.pharmacompass.com/pdf/news/cardinal-health-canada-inc-issues-recall-of-perox-a-mint-solution-1505197192.pdf
http://www.manufacturingchemist.com/news/article_page/Contec_launches_low_endotoxin_product_line/123527
http://www.fiercepharma.com/pharma/allergan-ceo-tamps-down-biogen-buyout-rumors-amid-q2-slip
Market Place
Share 
